Category

Insights from the Industry Blog Series

CluePoints – Finalists in The Clinical Informatics News 2017 Best Practices Awards at SCOPE, Jan 24th – 26th in Miami

By | Blog, Insights from the Industry Blog Series, News | No Comments

We’re thrilled to announce that CluePoints has been named as finalists for the Clinical Informatics News 2017 Best Practices Awards, for our award-winning Risk-Based Monitoring and Data Quality Oversight Solutions. The Clinical Informatics News Best Practices Awards recognize outstanding examples of applied strategic innovation – partnerships, deployments, and collaborations that manifestly improve the clinical trial process.

Risk-Based Monitoring Insights from the Industry: Angie Maurer

By | Blog, Insights from the Industry Blog Series | No Comments

Part Seven

In the latest of our eight-part ‘Insights from the Industry’ series, we caught up with Angie Maurer, Co-Founder & CEO at Zynapsys. Here’s what she had to share with us.

When it comes to the practical implementation of Risk-Based Monitoring, where do you observe differences in current best Risk-Based Monitoring practices between companies and CROs of different size?

Risk-Based Monitoring Insights from the Industry: Jamie O’Keefe

By | Blog, Insights from the Industry Blog Series | No Comments

Part Six

In the latest of our eight-part Q&A series, we catch up with Jamie O’Keefe, Vice President, Life Sciences, and R&D Practice at Paragon Solutions to get his thoughts on the latest issues in Risk-Based Monitoring (RBM).

When it comes to the practical implementation of Risk-Based Monitoring, where do you observe differences in current best Risk-Based Monitoring practices between companies and CROs of different size?

Risk-Based Monitoring Insights from the Industry: Dr. Peter Schiemann

By | Blog, Insights from the Industry Blog Series | No Comments

Part Four

In the fourth installment of the CluePoints Risk-Based Monitoring Q&A series, we spoke to Dr. Peter Schiemann, Managing Partner and Co-Founder of Widler & Schiemann, who had some interesting views to share with us

When it comes to the practical implementation of Risk-Based Monitoring, where do you observe differences in current best Risk-Based Monitoring practices between companies and CROs of different size?

Risk-Based Monitoring Insights from the Industry: Karen Fanouillere

By | Blog, Insights from the Industry Blog Series | No Comments

Part Three

In the third of an eight-part Q&A series which aims to explore some of the current hot topics in Risk-Based Monitoring (RBM), CluePoints has been speaking with Karen Fanouillere, Biostatistics Project Leader for 15 years and now Head of Clinical Information Governance at Sanofi about the perspectives of a large pharma company in implementing new monitoring methodologies for drug development programs.

Risk-Based Monitoring Insights from the Industry: Craig Serra

By | Blog, Insights from the Industry Blog Series | No Comments

Part One

In the first of an eight-part Q&A series which aims to explore some of the current hot topics in Risk-Based Monitoring (RBM), CluePoints has been speaking with Craig Serra from Pfizer. Craig is currently Senior Director and Data Management Business Process Owner, with accountability for the data management process in study conduct and closeout.